LEWISVILLE, Texas--(BUSINESS WIRE)--
As previously announced, Orthofix International N.V. (NASDAQ:OFIX), a
diversified, global medical device company, will be presenting on
Thursday, January 14, 2016 at the 34th Annual J.P. Morgan
Healthcare Conference. President and Chief Executive Officer Brad Mason
will represent the Company in a presentation scheduled for 8:00 a.m.
Pacific Time. A live audio webcast will be available on the Company's
website at www.orthofix.com
by clicking on the Investors tab and then clicking the link on the
Events and Presentations page.
The Company will be releasing written materials and other information,
including preliminary guidance regarding anticipated 2016 financial
performance, in connection with its presentation at approximately 4:00
p.m. Eastern Time on Tuesday, January 12, 2016. Such materials will be
available at http://ir.orthofix.com/events.cfm.
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units that include BioStim, Biologics,
Extremity Fixation and Spine Fixation. Orthofix products are widely
distributed via the Company's sales representatives, distributors and
its subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation and the Texas Scottish Rite
Hospital for Children. For more information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160111006587/en/
Orthofix International N.V.
Mark Quick, 214-937-2924
Source: Orthofix International N.V.
News Provided by Acquire Media